6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of January 2022

Alterity Therapeutics Limited

(Name of Registrant)

Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒       Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ☐         No  ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____

This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and our Registration Statements on Form F-3 (Files No. 333-251647, 333-249311, 333-231417 and 333-250076

ALTERITY THERAPEUTICS LIMITED

(a development stage enterprise)

The following exhibits are submitted:

99.1 Notification of cessation of securities - ATH

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Alterity Therapeutics Limited

/s/ Geoffrey P. Kempler

By: Geoffrey P. Kempler

Chairman

Date: January 4, 2022

2

EX-99.1

Exhibit 99.1

Notification of cessation of +securities 

Announcement Summary

Entity name

ALTERITY THERAPEUTICS LIMITED

Announcement Type 

New announcement

Date of this announcement

Wednesday January 05, 2022

Details of +securities that have ceased 

ASX +security code	Security description	Number of +securities that have ceased	The +securities have ceased due to	Date of cessation
ATHAAB	OPTION EXPIRING 17-SEP-2025 EX $0.09	14,000,000	Lapse of conditional right to 04/01/2022 securities because the conditions have not been, or have become incapable of being, satisfied	04/01/2022

Refer to next page for full details of the announcement

Notification of cessation of +securities 1 / 4

Notification of cessation of +securities 

Part 1 - Announcement Details

1.1 Name of +Entity

ALTERITY THERAPEUTICS LIMITED

We (the entity named above) provide the following information about our issued capital.

1.2 Registered Number Type	Registration Number
ABN	37080699065

1.3 ASX issuer code

ATH

1.4 The announcement is

þ New announcement

1.5 Date of this announcement 

5/1/2022

Notification of cessation of +securities 2 / 4

Notification of cessation of +securities 

Part 2 - Details of +equity securities or +debt securities that have ceased

ASX +Security Code and Description 

ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 

Unquoted +equity securities that have ceased

Number of securities that have ceased 

14,000,000

Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

Date of cessation	Is the entity paying any consideration for the cessation?
4/1/2022	þ  No

Any other information the entity wishes to notify to ASX about the cessation?

Notification of cessation of +securities 3 / 4

Notification of cessation of +securities 

Part 3 - Issued capital following changes

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)

ASX +security code and description	Total number of +securities on issue
ATH : ORDINARY FULLY PAID	2,406,874,578

3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

ASX +security code and description	Total number of +securities on issue
ATHAI : OPTION EXPIRING 31-JAN-2023 EX $0.083	700,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09	35,000,000
ATHAS : OPTION EXPIRING 06-JUN-2022 EX 7C	7,000,000
ATHAAA : OPTION EXPIRING 14-DEC-2022 EX 11C	12,450,000
ATHAAC : OPTION EXPIRING 23-NOV-2023 EX $0.07	674,694,939
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032	91,392,720

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

Notification of cessation of +securities 4 / 4